Figure 1From: Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patientsOverall survival of metastatic NSCLC patients. Patients received either systemic therapy, palliative local treatment without systemic therapy or no anti-cancer treatment. Median survival rates were 8.7, 2.9, and 1.3 months respectively (p < 0.001).Back to article page